We used general sensitivity to DNase I digestion to analyze the chromatin structure of c-myc genes in seven murine plasmacytomas. In every case, the 3' portion of c-myc juxtaposed with Ca displayed a much more DNase I-sensitive chromatin structure than untranslocated c-myc or, in one case analyzed, the reciprocally translocated 5' portion. Our data suggest the presence of regulatory sequences near the Ca gene segment.
Reciprocal translocations juxtapose the c-myc oncogene with immunoglobulin loci in murine plasmacytomas and human Burkitt lymphomas (1, 8, 9, 12-14, 17, 21, 26, 37, 40, 42) . Frequently, translocation in plasmacytomas removes the normal c-myc promoters, and the translocated c-myc gene is transcribed from cryptic promoters located in the intervening sequence 5' of the first coding exon (4, 5, 24, 34, 40) . Although steady-state levels of transcripts from such translocated genes vary, they are usually relatively high, whereas transcripts from the normal c-myc gene on the untranslocated chromosome are undetectable (1, 2, 4, 34, 40) . Recent studies (33) demonstrate that truncated c-myc mRNA which originates from translocated genes is more stable than normal c-myc mRNA. However, this finding does not explain why the cryptic c-myc promoters, which initiate transcription of the truncated mRNA, are activated after chromosomal translocation. We wish to understand at the molecular level the basis for the transcriptional activation of translocated c-myc genes.
The consistent juxtaposition of immunoglobulin sequences with the c-myc gene suggests that perhaps immunoglobulin sequences are responsible for this activation. In addition, somatic cell hybrid studies demonstrate that the cryptic promoters of truncated c-myc genes adjacent to immunoglobulin switch, and constant regions are active, in a B-cell background but not in lymphoblastoid or nonlymphoid cell backgrounds (10, 31, 32) . This demonstrates a requirement for B-cell-specific factors and suggests that B-cell factors normally involved in immunoglobulin gene transcription may also activate the cryptic c-myc promoters translocated adjacent to immunoglobulin genes. With few exceptions (7, 11, 16, 22, 39) , the known immunoglobulin heavy-chain enhancer (3, 19, 29, 30) does not remain on the same chromosome as the translocated c-myc gene and thus is not responsible for this activation (18, 24, 29, 35) . Since DNase I-sensitive structure is associated with active genes (23, 44 46) , we reasoned that an analysis of c-myc gene chromatin in plasmacytomas might provide insight into mechanisms responsible for activation of the cryptic promoters. A role for chromatin structure in the activation of translocated c-myc genes has been suggested previously (10, 25, 29, 33) . We now report that in seven different plasmacytomas the translocated c-myc gene shows a strikingly more open chromatin structure, as evidenced by general DNase I sensitivity, than that of the untranslocated allele.
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DNase I sensitivity was measured by preparing 1 x 108 to 2 x 108 nuclei by using 0.5% Triton X-100 and a Dounce homogenizer as previously described (41) . The nuclei were counted and adjusted to 108 nuclei per ml, and during incubation at 37°C, DNase I (Worthington; 5 to 14 ,ug/ml) was added. Samples were removed at selected times, and the digestion was stopped by adding 7 volumes of 4 mM EDTA (pH 7.5) and 1% sodium dodecyl sulfate. DNA samples were purified, restricted in standard conditions, and analyzed by Southern blotting using the hybridization conditions of Wahl et al. (43) .
We first studied murine plasmacytoma M603, in which translocation of the c-myc gene to a nonexpressed Ca gene segment removes the normal c-myc promoters and 5' noncoding exon and activates 15 cryptic promoters 5' of the first c-myc coding exon (34) . The restriction maps of the different CaK and c-myc genes in M603 are shown in Fig. 1 (6,   9, 34 ). The top map shows the normal c-myc gene on the nontranslocated chromosome 15. The next two maps show the 5' and 3' portions of the c-myc gene, which was divided by a reciprocal translocation with the CO, region of chromosome 12. The first noncoding c-myc exon is juxtaposed with the heavy-chain enhancer and JH region. The remaining two c-myc coding exons are juxtaposed with Ca. The last two maps show the other Ca alleles in M603. There are two to four copies of the functionally rearranged allele shown in the fourth map. The last map shows an abortive deleted form of the active CaX allele which is also present in M603. Indicated restriction fragments were used as probes in the following experiments. Figure 2 shows a DNase I analysis of c-myc and Ca genes in M603. In Fig. 2A, M603 DNA from DNase I-digested nuclei is shown in an ethidium bromide-stained agarose gel. Figure 2B shows a Southern blot of a HindIII digest of that DNA, hybridized with the IVS1 myc probe (Fig. 1) , and shows the sensitivity of the normal (4.5-kilobase [kb]) and 3' translocated (7.0-kb) c-myc genes. The translocated c-myc gene (7.0 kb) was much more sensitive to DNase I than the normal c-myc gene (4.5 kb). An experiment with a lower DNase I concentration yielded the same result ( Fig. 2G and  H) .
Two control experiments showed that the increased DNase I sensitivity of the translocated c-myc gene was not due to differences in the target size or sequence of the restriction fragments. First, differential sensitivity was not observed upon DNase I treatment of purified M603 DNA (data not shown). Second, an XbaI digest of the DNA in Nuclei from tumor or cell lines: TEPC1017 (6.8 ,ug/ml), a 8 producer; S107 (9.1 1Lg/ml), an a producer; MOPC104E (9.1 ±g/ml), a p. producer; J606 (9.1 p.g/ml), a -y3 producer with an undetermined translocation region; MOPC173 (6.8 ,ug/ml), a -y2a producer; HOPC1 (6.8 p.g/ml), a -y2a producer.
2A, hybridized with the IVS1 myc probe, yielded a normal c-myc fragment of 3.5 kb and a translocated fragment of 1.6 kb. Despite its smaller size, the translocated c-myc fragment was much more sensitive to the DNase I than the larger normal c-myc fragment (data not shown). In addition, the increased sensitivity of the translocated c-myc gene cannot be due to hypersensitive sites since no prominent hypersensitive sites were observed. A weak hypersensitive site was occasionally observed on overexposed autoradiograms, but this site was also observed in the normal c-myc gene of spleen, liver, and kidney. To determine the DNase I sensitivity of the Ca alleles, the blot in Fig. 2B was washed free of probe and hybridized with the 3' Ca probe. The autoradiogram shows a sensitive 7.0-kb fragment containing the Ca gene segment adjacent to c-myc and a 4.4-kb fragment which, although immediately sensitive to DNase I, persisted longer than the 7.0-kb fragment (Fig.  2C) . This is probably because the 4.4-kb fragment contains the abortive Ca gene and two to four copies of the active Ca gene. To assess the DNase I sensitivity of each Ca gene separately, a blot of an EcoRl digest was hybridized with the 5' Ca probe (Fig. 2D) . The 13.0-kb, 8.5-kb, and 5.1-kb EcoRI fragments represent the translocated, abortive, and expressed (two to four copies) Ca gene segments. All showed sensitivity to DNase I similar to that of the translocated c-myc gene. Identical results for the translocated c-myc gene and multiple Ca gene segments were obtained for plasmacytoma M167 (data not shown).
To study the sensitivity of a known inactive gene, the blot in Fig. 2C was washed and rehybridized with a ,B-globin probe ( Fig. 2E; 36) . The sensitivity of the 8.5-and 1.1-kb fragments was the same as that for the normal c-myc gene in Fig. 2B . The similar sensitivity of the 8.5-and 1.1-kb fragments further demonstrated that differences in target size are not critical in this analysis.
Finally, the 5' translocated c-myc gene was studied by hybridizing a blot of an XbaI digest with the 5' myc probe (Fig. 2F) . The normal (3.5-kb) and reciprocal 5' (4.2-kb) c-myc regions were relatively insensitive to DNase I, like the 3-globin gene. This demonstrated that translocation alone does not cause DNase I-sensitive chromatin structure and that the presence of the immunoglobulin enhancer adjacent to the 5' reciprocal fragment of c-myc is not sufficient to generate DNase I sensitivity such as that seen for the translocated c-myc gene and the C,, gene segments.
To confirm the observations made in plasmacytoma M603, we analyzed the DNase I sensitivity of the translocated c-myc genes in six other plasmacytoma tumor and cell lines (Fig. 3) . All of these plasmacytomas, except J606, have c-myc genes translocated to the Ca locus, although some of these tumors express isotypes other than alpha. M104E (immunoglobulin M) is unusual in that it has a c-myc gene translocated just 3' of the Ca gene (24) . In all cases, the translocated c-myc gene was significantly more sensitive to DNase I than the normal c-myc gene.
These results show that c-myc genes translocated to the Ca region acquire a different chromatin structure from their normal counterparts; their chromatin structure is very similar to that of expressed C genes. Two models for how the translocated c-myc genes acquired a sensitive chromatin structure are: (i) translocation into an active chromatin domain caused a change in c-myc chromatin which in turn activated the cryptic promoters, or (ii) juxtaposition with some cis-acting element near Ca activated the cryptic c-myc promoters, subsequently causing an open chromatin structure. In either case, our data show that translocation alone VOL. 6, 1986 did not cause the altered chromatin structure since the reciprocally translocated 5' c-myc region did not acquire the same structure. Furthermore, since activation of translocated c-myc genes requires a mature B-cell environment (10, 31, 32) , adjacent Ca sequences are causally implicated in this altered chromatin structure.
It has been suggested that additional enhancerlike regulatory elements may be located 3' of Ca (10, 38) . This possibility is consistent with the fact that translocations in plasmacytomas and Burkitt lymphomas nearly always retain the region 3' of C gene segments adjacent to c-myc. We have searched for another enhancer in a 5.5-kb region 3' to the translocation breakpoint and have not discovered any significant enhancing activity (20, 28, 29) . However, since the endogenous heavy-chain enhancer appears to activate tandem promoters located at least 17.5 kb away (43a), there may be a cis-acting element 3' of the region we have analyzed which could activate the cryptic c-myc promoters.
